Adrenocortical carcinoma | ApexOnco - Clinical Trials news and analysis

x

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Deals

2 July 2024

Lilly points in a new radiopharma direction

After being burned by Point, Lilly is taking a slower approach with Radionetics.

Subscribe to Adrenocortical carcinoma